Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children.

Authors: Adjei GO,Goka BQ,Binka F,Kurtzhals JA,
Address: Center for Tropical Clinical Pharmacology and Therapeutics, University of Ghana Medical School, College of Health Sciences, PO Box 4236, Accra, Ghana. goadjei@chs.edu.gh
Journal: Expert Rev Anti Infect Ther.

Publication: 2009 Aug;7(6):669-81. doi: 10.1586/eri.09.53.

abstract

Artemether-lumefantrine (AL; Coartem, Riamet) is the first fixed-dose artemisinin combination therapy (ACT) regimen to be manufactured under Good Manufacturing Practice conditions, and is the most widely adopted ACT regimen used in malaria control programs. AL is approved for the treatment of uncomplicated malaria in adults, children and infants, and as treatment of uncomplicated malaria in nonimmune travelers returning from malarious areas. AL is efficacious for treating uncomplicated malaria in children and the frequency of associated adverse events is not higher than other available ACT regimens. In this review, available evidence on efficacy and safety of AL in the treatment of uncomplicated malaria, with emphasis on children where appropriate, and focusing on characteristics that are potentially important for malaria control policy decisions, are presented and discussed.

Related Articles
A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
Malar J. 2008
A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
Juma EA, Obonyo CO, Akhwale WS, Ogutu BR. Malar J. 2008 Dec 22; 7:262. Epub 2008 Dec 22.
Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
Malar J. 2009
Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
Valecha N, Srivastava P, Mohanty SS, Mittra P, Sharma SK, Tyagi PK, Pradhan K, Dev V, Singh R, Dash AP, et al. Malar J. 2009 May 19; 8:107. Epub 2009 May 19.
Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.
Malar J. 2006
Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.
Mulenga M, VangGeertruyden JP, Mwananyanda L, Chalwe V, Moerman F, Chilengi R, Van Overmeir C, Dujardin JC, D'Alessandro U. Malar J. 2006 Aug 21; 5:73. Epub 2006 Aug 21.
Review Coartemether (artemether and lumefantrine): an oral antimalarial drug.
Expert Rev Anti Infect Ther. 2...
Review Coartemether (artemether and lumefantrine): an oral antimalarial drug.
Wernsdorfer WH. Expert Rev Anti Infect Ther. 2004 Apr; 2(2):181-96.
Review Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children.
Malar J. 2009
Review Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children.
Abdulla S, Sagara I. Malar J. 2009 Oct 12; 8 Suppl 1:S7. Epub 2009 Oct 12.
Review Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies.
Curr Opin Pediatr. 2010
Review Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies.
Yeka A, Harris JC. Curr Opin Pediatr. 2010 Dec; 22(6):798-803.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.